Edition:
United States

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

27.70USD
13 Aug 2018
Change (% chg)

-- (--)
Prev Close
$27.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
281,252
52-wk High
$35.99
52-wk Low
$15.09

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 7.68 -0.519
Mar '18 7.47 -0.508
FY 2017 Dec '17 6.67 -0.611
Sep '17 7.32 -0.436
Jun '17 5.92 -0.447
Mar '17 6.22 -0.364
FY 2016 Dec '16 5.63 -0.305
Sep '16 4.87 -0.218
Jun '16 4.21 -0.361
Mar '16 1.78 -0.191
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 11.84 25.40 7.12 13.45
Quarter Ending Dec-18 5 12.28 17.90 7.32 13.85
Year Ending Dec-18 6 37.87 58.40 29.59 38.55
Year Ending Dec-19 5 35.92 56.00 25.00 38.80
Earnings (per share)
Quarter Ending Sep-18 6 -0.47 -0.15 -0.63 -0.42
Quarter Ending Dec-18 6 -0.50 -0.39 -0.59 -0.47
Year Ending Dec-18 6 -2.00 -1.56 -2.25 -1.93
Year Ending Dec-19 6 -2.46 -1.94 -3.15 -2.56
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 189.67 32.45
P/E High - Last 5 Yrs. -- 277.06 47.22
P/E Low - Last 5 Yrs. -- 96.23 24.89
Beta -- 0.75 0.84
Price to Sales (TTM) 40.66 270.20 8.40
Price to Book (MRQ) 4.28 16.63 3.95
Price to Tangible Book (MRQ) 4.24 26.17 6.13
Price to Cash Flow (TTM) -- 116.67 22.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.74
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.43 -6.28
Payout Ratio(TTM) -- 6.23 46.26

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 29.74 149.11 6.78
Sales (TTM) vs TTM 1 Yr. Ago 28.74 94.76 11.71
Sales - 5 Yr. Growth Rate -- 30.18 7.70
EPS (MRQ) vs Qtr. 1 Yr. Ago -16.15 44.46 17.59
EPS (TTM) vs TTM 1 Yr. Ago -55.54 -- --
EPS - 5 Yr. Growth Rate -- 46.05 7.88
Capital Spending - 5 Yr. Growth Rate -- 41.85 7.92

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.54
Current Ratio (MRQ) 12.62 6.21 3.60
LT Debt to Equity (MRQ) 0.00 19.69 11.64
Total Debt to Equity (MRQ) 0.00 23.44 15.19
Interest Coverage (TTM) -- -174.61 30.66

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.85 55.22
Gross Margin - 5 Yr. Avg. -- 52.84 53.24
EBITD Margin (TTM) -284.60 -- --
EBITD - 5 Yr. Avg -- -183.34 15.81
Operating Margin (TTM) -297.33 -1,099.84 -2.73
Operating Margin - 5 Yr. Avg. -- -196.25 10.97
Pre-Tax Margin (TTM) -284.56 -985.70 -0.79
Pre-Tax Margin - 5 Yr. Avg. -- -197.42 11.15
Net Profit Margin (TTM) -284.56 -975.60 -3.99
Net Profit Margin - 5 Yr. Avg. -- -195.66 7.50
Effective Tax Rate (TTM) -- 12.19 20.47
Effective Tax Rate - 5 Yr. Avg. -- 19.18 24.19

Efficiency

  Company industry sector
Revenue/Employee (TTM) 149,390 23,157,838 736,438,167
Net Income/Employee (TTM) -425,097 -2,132,622 85,570,569
Receivable Turnover (TTM) 5.12 17.07 5.68
Inventory Turnover (TTM) -- 2.24 3.66
Asset Turnover (TTM) 0.10 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -27.41 0.46 10.27
Return on Assets - 5 Yr. Avg. -- 2.53 11.02
Return on Investment (TTM) -29.97 1.41 12.93
Return on Investment - 5 Yr. Avg. -- 2.06 14.23
Return on Equity (TTM) -35.51 0.54 15.12
Return on Equity - 5 Yr. Avg. -- -6.20 15.57
  1 Year 3 Year 5 Year
Sales % 58.49 -- --
EPS (TTM) % -31.78 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intellia Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -15.12 -16.08 39 31
13 Week 16.55 12.21 99 75
26 Week 17.84 8.96 99 61
52 Week 70.91 47.08 99 89
YTD 43.96 35.85 99 80
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 65.19%
# of Holders: 195
Total Shares Held: 28,160,831
3 Mo. Net Change: 470,170
# New Positions: 21
# Closed Positions: 12
# Increased Positions: 67
# Reduced Positions: 24
# Net Buyers: 43
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.